Buy Rating for Mersana Therapeutics: Promising XMT-1660 Trial Results and Market Opportunities
Justin Zelin, an analyst from BTIG, reiterated the Buy rating on Mersana Therapeutics (MRSN – Research Report). The associated price ...
Avricore Health Refocuses Strategy to Unlock Growth Potential
HealthTab™ has proven that it can rapidly scale nationally and elevate patient and practitioner experience with point-of-care testing in community pharmacy. It has also proven that the pharmacy ...
Inside Forward's failed attempt to revolutionize the doctor's office
Forward shuttered after raising $650 million for its AI doc-in-a-box. This is the definitive story of how the healthcare ...
Elon Musk took on another role, becoming Trump's efficiency boss. Here's the full list of his jobs.
The world's wealthiest man is the CEO of Tesla and SpaceX, and he has several other roles across his many companies.
alzheimersnewstoday6d
Modified Kisunla dosing shown to lower risk of ARIA-E in Alzheimer’s
Being started on a smaller dose of the approved early Alzheimer’s therapy Kisunla was found to reduce the risk of ARIA-E on imaging scans.